iANTHUS CAPITAL HOLDINGS (ITHUF) Net Margin (2020 - 2026)
iANTHUS CAPITAL HOLDINGS's (ITHUF) quarterly Net Margin came in at 42.7% in Q1 2026, down 5621.0% year-on-year from 0.77% in Q1 2025, and down 6.95% quarter-over-quarter from 39.93% in Q4 2025.
iANTHUS CAPITAL HOLDINGS (ITHUF) Net Margin (2020 - 2026) Analysis & Trends
iANTHUS CAPITAL HOLDINGS has disclosed Net Margin across 7 years of filings, most recently posting 42.7% for Q1 2026.
- Net Margin for Q1 2026 came in at 42.7%, down 5621.0% year-over-year; the trailing twelve-month figure through Mar 2026 was 42.81% (down 3747.0% YoY), and the FY2025 annual result was 27.92%, down 1127.0% from the prior year.
- Net Margin came in at 42.7% for Q1 2026 at iANTHUS CAPITAL HOLDINGS, down from 39.93% in the prior quarter.
- In the past five years, Net Margin ranged from a high of 17.6% in Q4 2024 to a low of 859.14% in Q2 2022.
- The 5-year median for Net Margin is 42.7% (2026), against an average of 86.68%.
- Across the five-year window, Net Margin tumbled 83101 bps in 2022 and surged 80709 bps in 2023, its largest moves.
- iANTHUS CAPITAL HOLDINGS's Net Margin stood at 116.4% in 2022, then surged by 61 bps to 45.73% in 2023, then surged by 138 bps to 17.6% in 2024, then slumped by 327 bps to 39.93% in 2025, then slipped by 7 bps to 42.7% in 2026.
- The last three Net Margin figures came in at 42.7% (Q1 2026), 39.93% (Q4 2025), and 35.45% (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 39.72 Bn | 35.98 Bn | 1.97 Bn | 9.19% |
| 2 | Zoetis | 34.61 Bn | 32.67 Bn | 1.62 Bn | 26.57% |
| 3 | United Therapeutics | 24.07 Bn | 21.91 Bn | 648.10 Mn | 35.18% |
| 4 | Aurora Cannabis | 16.98 Bn | 16.91 Bn | 33.43 Mn | 2.94% |
| 5 | Neurocrine Biosciences | 16.64 Bn | 15.32 Bn | 800.70 Mn | 24.30% |
| 6 | Elanco Animal Health | 12.19 Bn | 11.76 Bn | 785.00 Mn | 4.16% |
| 7 | Alkermes | 7.37 Bn | 6.86 Bn | -116.06 Mn | -168.42% |
| 8 | Hims & Hers Health | 6.62 Bn | 5.87 Bn | 396.79 Mn | -15.15% |
| 9 | Lantheus Holdings | 6.47 Bn | 5.97 Bn | 230.92 Mn | 31.38% |
| 10 | iANTHUS CAPITAL HOLDINGS | - | - | 15.92 Mn | -42.70% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -42.70% |
| Dec 31, 2025 | -39.93% |
| Sep 30, 2025 | -35.45% |
| Jun 30, 2025 | -53.20% |
| Mar 31, 2025 | 13.51% |
| Dec 31, 2024 | 17.60% |
| Sep 30, 2024 | -28.90% |
| Jun 30, 2024 | -22.77% |
| Mar 31, 2024 | -33.68% |
| Dec 31, 2023 | -45.73% |
| Sep 30, 2023 | -44.72% |
| Jun 30, 2023 | -52.04% |
| Mar 31, 2023 | -50.59% |
| Dec 31, 2022 | -116.40% |
| Sep 30, 2022 | -55.87% |
| Jun 30, 2022 | -859.14% |
| Mar 31, 2022 | -23.61% |
| Dec 31, 2021 | -56.47% |
| Sep 30, 2021 | -32.14% |
| Jun 30, 2021 | -28.13% |